Skip to main content
. 2021 Nov 12;28(6):4645–4654. doi: 10.3390/curroncol28060392

Table 1.

Attendee representative list.

Representative Sample Size
Health Canada representatives N = 2
PMPRB representatives N = 2
pCPA representatives N = 2
Clinicians—Medical Oncologists N = 7
CADTH/INESSS Staff N = 5
pERC Committee members (Current or Previous) N = 6
Public Drug Plan Administrators N = 8
Patient representatives N = 2
Academics N = 6

Note: Some attendees (n = 8) represent more than one perspective. Abbreviations: CADTH = Canadian Agency for Drugs and Technologies in Health; INESSS = Institute national d’excellence en santé et en services sociaux (INESSS); pCPA = pan-Canadian Pharmaceutical Alliance; pERC = pan-Canadian Oncology Drug Review Expert Review Committee. PMPRB = Patented Medicine Prices Review Board.